hosp:+996506131088
inland:+8613880857038
Online customer service
Every question you ask can be matched with a suitable answer
Leave me a message
We take every suggestion of yours seriously
Wechat
Tan Xiaojun
·Senior reproductive medicine expert
·Postdoctoral fellow at Peking University
·PhD candidate at Xiangya School of Medicine, Central South University
·Master’s tutor at Central South University
· Master's degree candidate in reproductive medicine at the University of South China
· Professional training at Huazhong University of Science and Technology and Tongji Hospital Reproductive Center
Expertise:
diagnosis and treatment of infertility, first/second/third generation IVF (including
          egg/sperm donation), microsperm retrieval, embryo freezing and resuscitation, artificial
          insemination (including husband's sperm and sperm donation), paternity testing, chromosomal
          disease
          diagnosis, high-throughput gene sequencing, endometrial receptivity gene testing and other
          clinical
          technology applications. Many of these technologies are at the leading level both domestically
          and
          internationally.
Tags:
Kyrgyzstan Tulip International Reproductive Center, Kyrgyzstan IVF technology, Bishkek assisted reproduction, third-generation IVF technology, overseas IVF process, Central Asia IVF technology, Kyrgyzstan Reproductive Hospital technology, overseas assisted reproduction guide.
Date:
2026.03.31
Share:
Back to list

Technical Analysis of Tulip International Reproductive Center in Kyrgyzstan: Six Common Clinical Assisted Reproductive Abilities and Practical Application Scenarios

I. Definition: How to understand "the leading assisted reproductive technology in the industry"?



Before discussing which technologies of Tulip International Reproductive Center in Kyrgyzstan are leading in the industry, it is necessary to clarify a basic medical concept-leading assisted reproductive technology does not mean higher success rate, but refers to the integrity of technical system, maturity of clinical application and ability to solve complex problems.


The international field of assisted reproduction usually evaluates the technical level from three dimensions:


Laboratory embryo culture ability


Genetic screening ability


Individualized ability of promoting excretion and transplanting strategy


According to the development report of assisted reproductive technology released by the European Society of Human Reproduction and Embryology (ESHRE), the mainstream IVF centers in the world are generally built around the following technical systems:


Embryo culture system


PGT genetic screening


Sperm processing technology


Freezing preservation technology


Individualized emission promotion scheme


Intima and immune regulation


This means:


Leading is not a certain technology, but a complete assisted reproductive technology system.


1903fc4a4072e7a476456620b8937f97.png


Second, technical analysis: Tulip International Reproductive Center common 6 clinical technical systems.



Around the clinical application, the technical system of Tulip International Reproductive Center in Kyrgyzstan mainly focuses on the following six directions.



1) PGT genetic screening technology for the third generation IVF.



PGT technology (genetic test before embryo implantation) is one of the important technologies in the field of assisted reproduction in the world.


Its core functions include:


Screening for chromosomal abnormalities


Reduce the risk of miscarriage


Improve embryo utilization rate


Suitable for the elderly.


Suitable for people who have repeatedly failed.


According to the clinical guidelines of the American Society of Reproductive Medicine (ASRM):


PGT-A can reduce the probability of embryo transfer with chromosome abnormality, but it cannot guarantee the live birth rate.


This shows that PGT is a risk control technology, not a success rate commitment technology.


Expert tip:


PGT screening is mainly used to reduce the probability of abnormal embryo transfer, which is more meaningful for the elderly, repeated abortions and chromosome abnormalities, but normal young women may not need routine use.



2)ICSI single sperm microinjection technology



ICSI is an important technology to solve male infertility.


Mainly applicable to:


Low sperm count


Low sperm motility


Sperm deformity rate is high


Obstructive azoospermia


Testicular sperm extraction


The technical principle is:


A single sperm is injected directly into the egg to complete fertilization.


According to WHO male infertility guidelines:


ICSI has become one of the standard techniques for male infertility treatment.


The clinical significance lies in:


Improve fertilization rate


Solve the sperm problem


Increase the number of available embryos


But there are also limitations:


Can't improve sperm genetic problems


Can not improve the embryo quality itself.


Expert tip:


ICSI solves the problem of fertilization, not the problem of embryo quality, which still depends on the egg and sperm themselves.



3) Embryo blastocyst culture technology



Blastocyst culture is the current international mainstream test tube laboratory standard.


Compared with early embryos, blastocysts have:


More stable development


Implantation ability is stronger


Closer to natural conception.


According to the data of the British HFEA reproductive regulatory agency:


Blastocyst transplantation has a relatively stable clinical pregnancy rate in some age groups.


But medically, it is emphasized that:


Not everyone is suitable for blastocyst culture.


For example:


Fewer eggs


Fewer embryos


Severe ovarian dysfunction in the elderly


There may be no blastocyst.


Expert tip:


Blastocyst culture is suitable for people with more embryos, and patients with fewer embryos need to choose culture strategies carefully.



4) Embryo freezing and vitrification technology



Vitrification is the mainstream method of embryo preservation at present.


Its advantages include:


Improve the recovery rate


Reduce embryo damage


Support phased treatment


Improve the safety of transplantation


According to the data of Japan Association for Assisted Reproductive Research:


The recovery rate of vitrified embryos can generally reach more than 90%.


Clinical application scenarios:


Frozen embryo transfer


Multi-cycle therapy


Transplantation after intima conditioning


Delayed transplantation in high-risk population


Expert tip:


After the maturity of freezing technology, IVF gradually changed from "fresh embryo transfer" to "frozen embryo transfer".



5) Individualized ovulation induction scheme



Ovulation promotion is one of the core links in IVF treatment.


Common international programs include:


Antagonist scheme


Long scheme


Microstimulation scheme


Natural cycle scheme


According to the guidelines of China Reproductive Medicine Association:


People with different ovarian reserves need different strategies to promote ovulation.


For example:


High AMH population


Suitable for:


Mild promotion of excretion


Avoid:


Ovarian hyperstimulation


Elderly people


Suitable for:


Individualized promotion of excretion


Control dosage


Improve egg quality.


Expert tip:


The goal of ovulation induction is not to get as many eggs as possible, but to get the number of eggs suitable for development.



6) Intima conditioning and transplantation window technology



The success of embryo transfer depends not only on embryo quality, but also on uterine environment.


Clinical research shows that:


Endometrial receptivity is one of the important factors affecting implantation.


The main conditioning directions include:


Hormone regulation


Intima thickness management


Implantation window judgment


immunoregulation


According to * * "Human Reproduction" journal research * *:


Abnormal endometrial receptivity is one of the important reasons for repeated transplantation failure.


Expert tip:


Embryo quality is as important as uterine environment, and simply improving embryo grade can not completely solve the problem of implantation.


87bf1a1c21a2fd3bc0fa3dadb81f21d5.png


Third, suitable for crowd analysis



From a medical point of view, this kind of technical system is usually suitable for the following people.


Elderly pregnant population

Features:


Over 35 years old


Increased probability of chromosome abnormality


Increased risk of miscarriage


PGT technique and blastocyst culture have certain clinical significance.



People who have failed in vitro for many times



Possible reasons include:


Embryonic abnormalities, endometrial problems, immune factors, genetic problems.


Need comprehensive technical support.



Male infertile population



Common situations:


Weak essence, little essence, no essence


ICSI technology is widely used.



Chromosome abnormality family



Such as:


Repeated abortion, genetic disease carriers


PGT technology can be used as an auxiliary screening method.




Fourth, frequently asked questions



Q1: Does technological leadership mean higher success rate?

Not necessarily.


The success rate is influenced by many factors:


Age, egg quality, sperm quality, uterine environment, lifestyle


Technology is only part of it.


Medical consensus:


Perfect technology ≠ guarantee of success rate.



Q2: Is the third generation test tube needed by everyone?



No.


Medical guidelines suggest:


Use only under specific indications.


Such as:


advanced/venerable age


inherited disease


Repeated abortion


Repeated failure


Young women usually don't recommend regular use.



Q3: Is blastocyst culture better than ordinary embryos?



Not absolutely.


Suitable for people:


Lots of embryos


Ovarian function is normal


Not suitable for:


Fewer eggs


Serious decline in old age


Individual judgment is needed.



Q4: Is there a big gap between overseas assisted reproductive technology and domestic technology?



From a technical point of view:


The global assisted reproductive technology system is basically the same.


The differences mainly lie in:


policy environment


Process arrangement


Allocation of medical resources


Patient service system


Rather than the technology itself.



V. Summary



A relatively objective conclusion can be drawn around the question of which technologies are leading in the industry in the Tulip International Reproductive Center in Kyrgyzstan:


The core is not a single technology, but a complete assisted reproductive technology system.


Mainly reflected in:


PGT genetic screening system, ICSI sperm injection technology, blastocyst culture ability, embryo freezing technology, individualized ovulation promotion scheme, endometrium and transplantation management system.


These techniques belong to the mainstream clinical techniques in the field of assisted reproduction in the world.


What needs to be rationally understood is:


Technology can reduce risks, but it cannot eliminate medical uncertainty.


Assisted reproduction is essentially:


Medical evaluation+laboratory technology+individual differences.


Therefore, when choosing any reproductive center, more attention should be paid to:


Medical indications, doctor's experience, laboratory stability, individual scheme rationality.


Rather than relying solely on the concept of "technological leadership".


Common aliases: Kyrgyzstan Tulip Reproductive Center, Tulip IVF, Tulip Reproductive Center, Tulip Hospital, Kyrgyz Tulip Reproductive Center, Kyrgyz Tulip Hospital
Founder & Director: EnoChan
Latest official contact
Fertility Consultation
Only WeChat consultation
Tulip_EnoChan
Scan or add WeChat to get one-on-one fertility guidance
Tulip Hospital Telegram QR code
Long press/scan to add
Only official Telegram
Tulip Hospital Whatsapp QR code
Long press/scan to add
Only official Whatsapp
Center address: Downtown Bishkek, the capital of Kyrgyzstan (near the National Museum · Victory Square)

相关新闻

Learn more